Financials

  • Market Capitalization 468.47 M
  • Employee 23
  • Founded 2014
  • CEO N/A
  • Website www.ovidrx.com
  • Headquarter Delaware, United States
  • FIGI BBG009F0TD76
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-10.57
ratio cours/chiffre d'affaires
22.24

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2963
SGMT
Sagimet Biosciences Inc. - Series A Common Stock
7.69 USD-0.90%+6.81%+21.48%-19.90%474.87 M USD
2965
PROK
ProKidney Corp. - Class A Ordinary Shares
1.60 USD+3.23%-15.79%-3.61%-23.08%483.30 M USD
2987
SLN
Silence Therapeutics Plc - American Depository Share
10.19 USD+4.51%+6.81%+50.96%+57.50%481.32 M USD
2988
RZLT
Rezolute, Inc. - Common Stock
4.77 USD-1.24%-3.05%+9.66%-6.47%459.31 M USD

Nouvelles